Changing Fibroid Treatment Protocols: Reactions to FDA Warnings on Power Morcellation

The "FDA Jury" is out on treatment for uterine fibroids, and it’s not favorable to the practice of laparoscopic power morcellation. That update, and more importantly an expert practitioner’s perspectives on the FDA's suggested recommendations, is the focus of this interview. Joining Dr. Matt Birnholz to discuss the current landscape in uterine fibroid treatments, and the changing perceptions on power morcellation procedures, is Dr. Michael Randell, practicing OB/GYN in the Department of Obstetrics and Gynecology at Northside Hospital in Atlanta, GA. Dr. Randell is a Diplomat of the American Board of Obstetrics and Gynecology and the National Board of Medical Examiners.